Login to Your Account



BioLineRx Prices $50M IPO, Listing On Tel Aviv Exchange

By Jennifer Boggs


Thursday, February 8, 2007
Israeli drug development firm BioLineRx Ltd. gained a listing on the Tel Aviv Stock Exchange and brought in $50 million in an oversubscribed initial public offering. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription